Bulletin
Investor Alert

Biogen Inc.

NAS: BIIB

GO
/marketstate/country/us

After Hours

/zigman2/quotes/201531540/composite

$

270.00

Change

-3.28 -1.20%

Volume

Volume 55,712

Sep 25, 2020, 7:56 p.m.

Real time quotes

/zigman2/quotes/201531540/composite

Today's close

$ 270.04

$ 273.28

Change

+3.24 +1.20%

Day low

Day high

$267.50

$274.26

Open
Open: 268.29

52 week low

52 week high

$219.70

$374.99

Open

Market cap

$42.75B

Average volume

1.20M

P/E ratio

8.01

Rev. per Employee

$1.55M

EPS

34.14

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/biib

MarketWatch News on BIIB

  1. A Dozen Beaten-Up Stocks That Can Rocket Higher

    8:59 a.m. Sept. 16, 2020

    - Al Root

  2. It’s Time to Buy Eli Lilly Stock, Analyst Says

    10:15 a.m. Sept. 3, 2020

    - Josh Nathan-Kazis

  3. Exxon and Pfizer Booted From the Dow

    10:11 a.m. Aug. 25, 2020

    - Ben Levisohn

  4. 5 New Stocks That Are Hedge Funds’ Favorites

    3:44 p.m. Aug. 21, 2020

    - Carleton English

  5. FDA approves Roche's new spinal muscular atrophy drug

    10:40 a.m. Aug. 8, 2020

    - Jaimy Lee

  6. Here’s What Kodak Pharmaceutical Might Be Worth

    7:59 a.m. Aug. 5, 2020

    - Al Root

  7. Biogen Gains, Hasbro Drops as the Dow Inches Higher

    1:48 p.m. July 27, 2020

    - Teresa Rivas

  8. Biogen double upgraded to overweight at Morgan Stanley

    11:16 a.m. July 27, 2020

    - Tomi Kilgore

  9. Buy Biogen Stock, Says Morgan Stanley, Because the Time Is Right

    10:20 a.m. July 27, 2020

    - Josh Nathan-Kazis

  10. Stocks Edge Ahead on Vaccine, Earnings Hopes

    1:01 p.m. July 22, 2020

    - Teresa Rivas

  11. Biogen Beats Earnings Expectations but Leaves a Mystery on CFO

    9:02 a.m. July 22, 2020

    - Josh Nathan-Kazis

  12. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/biib

Other News on BIIB

  1. Biotech Short Sellers Hike Their Bets

    9:05 a.m. Today

    - 247WallSt.com

  2. Wide-Moat Stocks On Sale - The October 2020 Heat Map

    2:24 a.m. Today

    - Seeking Alpha

  3. AC Immune's Candidate Fails in Alzheimer's Disease Study

    10:35 a.m. Sept. 24, 2020

    - Zacks.com

  4. 5 Predictable Stocks With a Margin of Safety

    10:50 a.m. Sept. 22, 2020

    - GuruFocus.com

  5. Warren Buffett Dials Down DaVita Stake

    10:17 a.m. Sept. 22, 2020

    - GuruFocus.com

  6. IPO Update: Inhibikase Therapeutics Proposes IPO Terms

    11:30 a.m. Sept. 17, 2020

    - Seeking Alpha

  7. XLV: Healthcare Dashboard For September

    10:11 a.m. Sept. 16, 2020

    - Seeking Alpha

  8. Alexion Pharma up 7% on rumored Biogen interest

    3:42 p.m. Sept. 15, 2020

    - Seeking Alpha

  9. Short Sellers Hike Their Bets in Major Biotechs

    9:22 a.m. Sept. 11, 2020

    - 247WallSt.com

  10. 5 Companies Expanding Book Value

    1:12 p.m. Sept. 9, 2020

    - GuruFocus.com

  11. Roche Expands Multiple Sclerosis Portfolio, Starts Studies

    10:12 a.m. Sept. 9, 2020

    - Zacks.com

  12. Yumanity Therapeutics to Join Public Markets Via Merger

    4:38 p.m. Sept. 3, 2020

    - GuruFocus.com

  13. ALS Drug Study Signals Progress Toward Treatment for Deadly Disease

    5:00 p.m. Sept. 2, 2020

    - Jonathan D. Rockoff

  14. Loading more headlines...
/news/pressrelease/company/us/biib

Press Releases on BIIB

  1. Spinal Muscular Atrophy (SMA) Treatment Market Size to accrue $ 1179.6 million by 2025

    1:55 a.m. Today

    - Market Insight Reports

  2. At 8.1% CAGR, Solid Tumor Therapeutics Market Size is Expected to Exhibit US$ 156810 million by 2025

    1:52 a.m. Today

    - Market Insight Reports

  3. Multiple Sclerosis Therapeutics Market Global Research and Clinical Survey Report 2020 to 2025

    12:29 a.m. Today

    - Market Insight Reports

  4. Loading more headlines...

Rates »

Link to MarketWatch's Slice.